Product Pipeline

AGTII is building a rich product pipeline based on its bio-safe, multi-gene vectors.  Multiple products have passed the design phase and several product candidates are in the laboratory testing phase for oncology indications.

In addition to the above referenced programs, AGTII’s proprietary technology will support development of therapeutics to address unmet needs in genetic medicine, stem cell therapy, and cosmetic applications.